The growth in the continuous bioprocessing market is mainly attributed to the boost in demand for biopharmaceuticals, the fast pace of development in new technologies and products related to continuous bioprocessing, and rising government support for biopharmaceutical manufacturing, finds the report.
Continuous bioprocessing
Continuous bioprocessing consists of integrated continuous unit processes without intermediate holding tanks through which product travels into containers in a constant flow.
Continuous unit operations are characterized by extremely intensified processing with short downtimes.
An end-to-end bioprocess includes perfusion bioreactors, multi-column chromatography systems, and multi-column intermediate purification systems.
Some pharma and biopharma manufacturers are adopting a hybrid approach to continuous bioprocessing in which only upstream or downstream process is operated continuously.